 | • レポートコード：GIR201114669 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、新ドラッグデリバリーシステムの世界市場を調査対象にし、新ドラッグデリバリーシステムの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（リポソーム、PEG化タンパク質・ポリペプチド、ポリマーナノ粒子、タンパク質-薬物複合体、その他）、用途別分析（病院・クリニック、がん治療センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Amgen、Sanofi、UCB(Union Chimique Belge)、Teva、Gilead Sciences、Roche、Takeda、Merck、Celgene、Pfizer、Astellas、Dr Reddy、Bausch＆Lomb、Aspen、AMAG Pharmaceuticals、TOLMAR、Samyang Biopharmaceuticals、AstraZeneca、AbbVie、Johnson & Johnson、Acrotech Biopharma、TWi Pharmaceuticals ・企業別売上、市場シェア ・新ドラッグデリバリーシステムの地域別市場分析 ・新ドラッグデリバリーシステムの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・新ドラッグデリバリーシステムのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・新ドラッグデリバリーシステムのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・新ドラッグデリバリーシステムの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・新ドラッグデリバリーシステムの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・新ドラッグデリバリーシステムの種類別市場規模2015-2020：リポソーム、PEG化タンパク質・ポリペプチド、ポリマーナノ粒子、タンパク質-薬物複合体、その他 ・新ドラッグデリバリーシステムの用途別市場規模2015-2020：病院・クリニック、がん治療センター、その他 ・新ドラッグデリバリーシステムの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Novel Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Novel Drug Delivery Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 26530 million by 2025, from USD 24870 million in 2019.
Market segmentation
Novel Drug Delivery Systems market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Novel Drug Delivery Systems market has been segmented into:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
By Application, Novel Drug Delivery Systems has been segmented into:
Hospitals & Clinic
Cancer Treatment Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Novel Drug Delivery Systems market presented in the report. This section sheds light on the sales growth of different regional and country-level Novel Drug Delivery Systems markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Novel Drug Delivery Systems market.
The report offers in-depth assessment of the growth and other aspects of the Novel Drug Delivery Systems market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Novel Drug Delivery Systems Market Share Analysis
Novel Drug Delivery Systems competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Novel Drug Delivery Systems sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Novel Drug Delivery Systems sales, revenue and market share for each player covered in this report.
The major players covered in Novel Drug Delivery Systems are:
Amgen
Sanofi
UCB(Union Chimique Belge)
Teva
Gilead Sciences
Roche
Takeda
Merck
Celgene
Pfizer
Astellas
Dr Reddy
Bausch＆Lomb
Aspen
AMAG Pharmaceuticals
TOLMAR
Samyang Biopharmaceuticals
AstraZeneca
AbbVie
Johnson & Johnson
Acrotech Biopharma
TWi Pharmaceuticals
Among other players domestic and global, Novel Drug Delivery Systems market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Novel Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Novel Drug Delivery Systems
1.2 Classification of Novel Drug Delivery Systems by Type
1.2.1 Global Novel Drug Delivery Systems Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Novel Drug Delivery Systems Revenue Market Share by Type in 2019
1.2.3 Liposomes
1.2.4 PEGylated Proteins & Polypeptides
1.2.5 Polymer Nanoparticle
1.2.6 Protein–drug Conjugates
1.2.7 Others
1.3 Global Novel Drug Delivery Systems Market by Application
1.3.1 Overview: Global Novel Drug Delivery Systems Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Novel Drug Delivery Systems Market by Regions
1.4.1 Global Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Novel Drug Delivery Systems (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Novel Drug Delivery Systems Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Novel Drug Delivery Systems Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Novel Drug Delivery Systems Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Novel Drug Delivery Systems Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Novel Drug Delivery Systems Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.3 UCB(Union Chimique Belge)
2.3.1 UCB(Union Chimique Belge) Details
2.3.2 UCB(Union Chimique Belge) Major Business
2.3.3 UCB(Union Chimique Belge) SWOT Analysis
2.3.4 UCB(Union Chimique Belge) Product and Services
2.3.5 UCB(Union Chimique Belge) Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gilead Sciences
2.5.1 Gilead Sciences Details
2.5.2 Gilead Sciences Major Business
2.5.3 Gilead Sciences SWOT Analysis
2.5.4 Gilead Sciences Product and Services
2.5.5 Gilead Sciences Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Product and Services
2.6.4 Roche Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Product and Services
2.7.4 Takeda Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Product and Services
2.8.4 Merck Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celgene
2.9.1 Celgene Details
2.9.2 Celgene Major Business
2.9.3 Celgene Product and Services
2.9.4 Celgene Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Product and Services
2.10.4 Pfizer Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Product and Services
2.11.4 Astellas Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dr Reddy
2.12.1 Dr Reddy Details
2.12.2 Dr Reddy Major Business
2.12.3 Dr Reddy Product and Services
2.12.4 Dr Reddy Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bausch＆Lomb
2.13.1 Bausch＆Lomb Details
2.13.2 Bausch＆Lomb Major Business
2.13.3 Bausch＆Lomb Product and Services
2.13.4 Bausch＆Lomb Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.14 Aspen
2.14.1 Aspen Details
2.14.2 Aspen Major Business
2.14.3 Aspen Product and Services
2.14.4 Aspen Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.15 AMAG Pharmaceuticals
2.15.1 AMAG Pharmaceuticals Details
2.15.2 AMAG Pharmaceuticals Major Business
2.15.3 AMAG Pharmaceuticals Product and Services
2.15.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.16 TOLMAR
2.16.1 TOLMAR Details
2.16.2 TOLMAR Major Business
2.16.3 TOLMAR Product and Services
2.16.4 TOLMAR Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.17 Samyang Biopharmaceuticals
2.17.1 Samyang Biopharmaceuticals Details
2.17.2 Samyang Biopharmaceuticals Major Business
2.17.3 Samyang Biopharmaceuticals Product and Services
2.17.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.18 AstraZeneca
2.18.1 AstraZeneca Details
2.18.2 AstraZeneca Major Business
2.18.3 AstraZeneca Product and Services
2.18.3 AstraZeneca Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.19 AbbVie
2.19.1 AbbVie Details
2.19.2 AbbVie Major Business
2.19.3 AbbVie Product and Services
2.19.4 AbbVie Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.20 Johnson & Johnson
2.20.1 Johnson & Johnson Details
2.20.2 Johnson & Johnson Major Business
2.20.3 Johnson & Johnson Product and Services
2.20.4 Johnson & Johnson Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.21 Acrotech Biopharma
2.21.1 Acrotech Biopharma Details
2.21.2 Acrotech Biopharma Major Business
2.21.3 Acrotech Biopharma Product and Services
2.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
2.22 TWi Pharmaceuticals
2.22.1 TWi Pharmaceuticals Details
2.22.2 TWi Pharmaceuticals Major Business
2.22.3 TWi Pharmaceuticals Product and Services
2.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Novel Drug Delivery Systems Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Novel Drug Delivery Systems Players Market Share
3.2.2 Top 10 Novel Drug Delivery Systems Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Novel Drug Delivery Systems Revenue and Market Share by Regions
4.2 North America Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
4.3 Europe Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
4.5 South America Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
5 North America Novel Drug Delivery Systems Revenue by Countries
5.1 North America Novel Drug Delivery Systems Revenue by Countries (2015-2020)
5.2 USA Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
5.3 Canada Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
5.4 Mexico Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
6 Europe Novel Drug Delivery Systems Revenue by Countries
6.1 Europe Novel Drug Delivery Systems Revenue by Countries (2015-2020)
6.2 Germany Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
6.3 UK Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
6.4 France Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
6.5 Russia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
6.6 Italy Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Novel Drug Delivery Systems Revenue by Countries
7.1 Asia-Pacific Novel Drug Delivery Systems Revenue by Countries (2015-2020)
7.2 China Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
7.3 Japan Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
7.4 Korea Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
7.5 India Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
8 South America Novel Drug Delivery Systems Revenue by Countries
8.1 South America Novel Drug Delivery Systems Revenue by Countries (2015-2020)
8.2 Brazil Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
8.3 Argentina Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Novel Drug Delivery Systems by Countries
9.1 Middle East & Africa Novel Drug Delivery Systems Revenue by Countries (2015-2020)
9.2 Saudi Arabia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
9.3 UAE Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
9.4 Egypt Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
9.5 South Africa Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2015-2020)
10.2 Global Novel Drug Delivery Systems Market Forecast by Type (2019-2024)
10.3 Liposomes Revenue Growth Rate (2015-2025)
10.4 PEGylated Proteins & Polypeptides Revenue Growth Rate (2015-2025)
10.5 Polymer Nanoparticle Revenue Growth Rate (2015-2025)
10.6 Protein–drug Conjugates Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Novel Drug Delivery Systems Market Segment by Application
11.1 Global Novel Drug Delivery Systems Revenue Market Share by Application (2015-2020)
11.2 Novel Drug Delivery Systems Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinic Revenue Growth (2015-2020)
11.4 Cancer Treatment Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Novel Drug Delivery Systems Market Size Forecast (2021-2025)
12.1 Global Novel Drug Delivery Systems Market Size Forecast (2021-2025)
12.2 Global Novel Drug Delivery Systems Market Forecast by Regions (2021-2025)
12.3 North America Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
12.4 Europe Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
12.6 South America Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Novel Drug Delivery Systems Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Novel Drug Delivery Systems Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Novel Drug Delivery Systems Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Novel Drug Delivery Systems Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Amgen Corporate Information, Location and Competitors
Table 7. Amgen Novel Drug Delivery Systems Major Business
Table 8. Amgen Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 9. Amgen SWOT Analysis
Table 10. Amgen Novel Drug Delivery Systems Product and Solutions
Table 11. Amgen Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sanofi Corporate Information, Location and Competitors
Table 13. Sanofi Novel Drug Delivery Systems Major Business
Table 14. Sanofi Novel Drug Delivery Systems Total Revenue (USD Million) (2018-2019)
Table 15. Sanofi SWOT Analysis
Table 16. Sanofi Novel Drug Delivery Systems Product and Solutions
Table 17. Sanofi Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. UCB(Union Chimique Belge) Corporate Information, Location and Competitors
Table 19. UCB(Union Chimique Belge) Novel Drug Delivery Systems Major Business
Table 20. UCB(Union Chimique Belge) Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 21. UCB(Union Chimique Belge) SWOT Analysis
Table 22. UCB(Union Chimique Belge) Novel Drug Delivery Systems Product and Solutions
Table 23. UCB(Union Chimique Belge) Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Teva Corporate Information, Location and Competitors
Table 25. Teva Novel Drug Delivery Systems Major Business
Table 26. Teva Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 27. Teva SWOT Analysis
Table 28. Teva Novel Drug Delivery Systems Product and Solutions
Table 29. Teva Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Gilead Sciences Corporate Information, Location and Competitors
Table 31. Gilead Sciences Novel Drug Delivery Systems Major Business
Table 32. Gilead Sciences Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 33. Gilead Sciences SWOT Analysis
Table 34. Gilead Sciences Novel Drug Delivery Systems Product and Solutions
Table 35. Gilead Sciences Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Roche Corporate Information, Location and Competitors
Table 37. Roche Novel Drug Delivery Systems Major Business
Table 38. Roche Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 39. Roche SWOT Analysis
Table 40. Roche Novel Drug Delivery Systems Product and Solutions
Table 41. Roche Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Takeda Corporate Information, Location and Competitors
Table 43. Takeda Novel Drug Delivery Systems Major Business
Table 44. Takeda Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 45. Takeda SWOT Analysis
Table 46. Takeda Novel Drug Delivery Systems Product and Solutions
Table 47. Takeda Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Merck Corporate Information, Location and Competitors
Table 49. Merck Novel Drug Delivery Systems Major Business
Table 50. Merck Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 51. Merck SWOT Analysis
Table 52. Merck Novel Drug Delivery Systems Product and Solutions
Table 53. Merck Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Celgene Corporate Information, Location and Competitors
Table 55. Celgene Novel Drug Delivery Systems Major Business
Table 56. Celgene Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 57. Celgene SWOT Analysis
Table 58. Celgene Novel Drug Delivery Systems Product and Solutions
Table 59. Celgene Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Pfizer Corporate Information, Location and Competitors
Table 61. Pfizer Novel Drug Delivery Systems Major Business
Table 62. Pfizer Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 63. Pfizer SWOT Analysis
Table 64. Pfizer Novel Drug Delivery Systems Product and Solutions
Table 65. Pfizer Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Astellas Corporate Information, Location and Competitors
Table 67. Astellas Novel Drug Delivery Systems Major Business
Table 68. Astellas Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 69. Astellas SWOT Analysis
Table 70. Astellas Novel Drug Delivery Systems Product and Solutions
Table 71. Astellas Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Dr Reddy Corporate Information, Location and Competitors
Table 73. Dr Reddy Novel Drug Delivery Systems Major Business
Table 74. Dr Reddy Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 75. Dr Reddy SWOT Analysis
Table 76. Dr Reddy Novel Drug Delivery Systems Product and Solutions
Table 77. Dr Reddy Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Bausch＆Lomb Corporate Information, Location and Competitors
Table 79. Bausch＆Lomb Novel Drug Delivery Systems Major Business
Table 80. Bausch＆Lomb Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 81. Bausch＆Lomb SWOT Analysis
Table 82. Bausch＆Lomb Novel Drug Delivery Systems Product and Solutions
Table 83. Bausch＆Lomb Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Aspen Corporate Information, Location and Competitors
Table 85. Aspen Novel Drug Delivery Systems Major Business
Table 86. Aspen Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 87. Aspen SWOT Analysis
Table 88. Aspen Novel Drug Delivery Systems Product and Solutions
Table 89. Aspen Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. AMAG Pharmaceuticals Corporate Information, Location and Competitors
Table 91. AMAG Pharmaceuticals Novel Drug Delivery Systems Major Business
Table 92. AMAG Pharmaceuticals Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 93. AMAG Pharmaceuticals SWOT Analysis
Table 94. AMAG Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 95. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. TOLMAR Corporate Information, Location and Competitors
Table 97. TOLMAR Novel Drug Delivery Systems Major Business
Table 98. TOLMAR Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 99. TOLMAR SWOT Analysis
Table 100. TOLMAR Novel Drug Delivery Systems Product and Solutions
Table 101. TOLMAR Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Samyang Biopharmaceuticals Corporate Information, Location and Competitors
Table 103. Samyang Biopharmaceuticals Novel Drug Delivery Systems Major Business
Table 104. Samyang Biopharmaceuticals Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 105. Samyang Biopharmaceuticals SWOT Analysis
Table 106. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 107. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. AstraZeneca Novel Drug Delivery Systems Type and Application
Table 109. AstraZeneca Novel Drug Delivery Systems Major Business
Table 110. AstraZeneca Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 111. AstraZeneca SWOT Analysis
Table 112. AstraZeneca Novel Drug Delivery Systems Product and Solutions
Table 113. AstraZeneca Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. AbbVie Corporate Information, Location and Competitors
Table 115. AbbVie Novel Drug Delivery Systems Major Business
Table 116. AbbVie Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 117. AbbVie SWOT Analysis
Table 118. AbbVie Novel Drug Delivery Systems Product and Solutions
Table 119. AbbVie Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Johnson & Johnson Corporate Information, Location and Competitors
Table 121. Johnson & Johnson Novel Drug Delivery Systems Major Business
Table 122. Johnson & Johnson Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 123. Johnson & Johnson SWOT Analysis
Table 124. Johnson & Johnson Novel Drug Delivery Systems Product and Solutions
Table 125. Johnson & Johnson Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Acrotech Biopharma Corporate Information, Location and Competitors
Table 127. Acrotech Biopharma Novel Drug Delivery Systems Major Business
Table 128. Acrotech Biopharma Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 129. Acrotech Biopharma SWOT Analysis
Table 130. Acrotech Biopharma Novel Drug Delivery Systems Product and Solutions
Table 131. Acrotech Biopharma Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. TWi Pharmaceuticals Corporate Information, Location and Competitors
Table 133. TWi Pharmaceuticals Novel Drug Delivery Systems Major Business
Table 134. TWi Pharmaceuticals Novel Drug Delivery Systems Total Revenue (USD Million) (2017-2018)
Table 135. TWi Pharmaceuticals SWOT Analysis
Table 136. TWi Pharmaceuticals Novel Drug Delivery Systems Product and Solutions
Table 137. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. Global Novel Drug Delivery Systems Revenue (Million USD) by Players (2015-2020)
Table 139. Global Novel Drug Delivery Systems Revenue Share by Players (2015-2020)
Table 140. Global Novel Drug Delivery Systems Revenue (Million USD) by Regions (2015-2020)
Table 141. Global Novel Drug Delivery Systems Revenue Market Share by Regions (2015-2020)
Table 142. North America Novel Drug Delivery Systems Revenue by Countries (2015-2020)
Table 143. North America Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Table 144. Europe Novel Drug Delivery Systems Revenue (Million USD) by Countries (2015-2020)
Table 145. Asia-Pacific Novel Drug Delivery Systems Revenue (Million USD) by Countries (2015-2020)
Table 146. South America Novel Drug Delivery Systems Revenue by Countries (2015-2020)
Table 147. South America Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Table 148. Middle East and Africa Novel Drug Delivery Systems Revenue (Million USD) by Countries (2015-2020)
Table 149. Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Table 150. Global Novel Drug Delivery Systems Revenue (Million USD) by Type (2015-2020)
Table 151. Global Novel Drug Delivery Systems Revenue Share by Type (2015-2020)
Table 152. Global Novel Drug Delivery Systems Revenue Forecast by Type (2021-2025)
Table 153. Global Novel Drug Delivery Systems Revenue by Application (2015-2020)
Table 154. Global Novel Drug Delivery Systems Revenue Share by Application (2015-2020)
Table 155. Global Novel Drug Delivery Systems Revenue Forecast by Application (2021-2025)
Table 156. Global Novel Drug Delivery Systems Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Novel Drug Delivery Systems Picture
Figure 2. Global Novel Drug Delivery Systems Revenue Market Share by Type in 2019
Figure 3. Liposomes Picture
Figure 4. PEGylated Proteins & Polypeptides Picture
Figure 5. Polymer Nanoparticle Picture
Figure 6. Protein–drug Conjugates Picture
Figure 7. Others Picture
Figure 8. Novel Drug Delivery Systems Revenue Market Share by Application in 2019
Figure 9. Hospitals & Clinic Picture
Figure 10. Cancer Treatment Centers Picture
Figure 11. Others Picture
Figure 12. Global Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Novel Drug Delivery Systems Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Novel Drug Delivery Systems Revenue Market Share in 2019
Figure 21. Global Top 10 Players Novel Drug Delivery Systems Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Novel Drug Delivery Systems Revenue Market Share by Regions (2015-2020)
Figure 25. Global Novel Drug Delivery Systems Revenue Market Share by Regions in 2018
Figure 26. North America Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 27. Europe Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 29. South America Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 31. North America Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Figure 32. North America Novel Drug Delivery Systems Revenue Market Share by Countries in 2019
Figure 33. USA Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 34. Canada Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 36. Europe Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Novel Drug Delivery Systems Revenue Market Share by Countries in 2019
Figure 38. Germany Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 39. UK Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 40. France Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 41. Russia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 42. Italy Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Countries in 2019
Figure 45. China Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 46. Japan Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 47. Korea Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 48. India Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 50. South America Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Figure 51. South America Novel Drug Delivery Systems Revenue Market Share by Countries in 2019
Figure 52. Brazil Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 57. UAE Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Novel Drug Delivery Systems Revenue and Growth Rate (2015-2020)
Figure 60. Global Novel Drug Delivery Systems Revenue Share by Type (2015-2020)
Figure 61. Global Novel Drug Delivery Systems Revenue Share by Type in 2019
Figure 62. Global Novel Drug Delivery Systems Market Share Forecast by Type (2021-2025)
Figure 63. Global Liposomes Revenue Growth Rate (2015-2020)
Figure 64. Global PEGylated Proteins & Polypeptides Revenue Growth Rate (2015-2020)
Figure 65. Global Polymer Nanoparticle Revenue Growth Rate (2015-2020)
Figure 66. Global Protein–drug Conjugates Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Novel Drug Delivery Systems Revenue Share by Application (2015-2020)
Figure 69. Global Novel Drug Delivery Systems Revenue Share by Application in 2019
Figure 70. Global Novel Drug Delivery Systems Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals & Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Treatment Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Novel Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Novel Drug Delivery Systems Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Novel Drug Delivery Systems Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
Figure 78. Europe Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
Figure 80. South America Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Novel Drug Delivery Systems Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
経肺薬剤送達システムの世界市場 2020年 Market Overview The Pulmonary Drug Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 経皮・経粘膜ドラッグデリバリーの世界市場 2020年 Market Overview The global Transdermal and Transmucosal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tr…
- MRI薬物送達の世界市場 2020年 Market Overview The global MRI Guided Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The MRI Guided Drug Deli…
- 鼻腔内薬物送達デバイスの世界市場 2020年 Market Overview The Intranasal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- バイオ医薬品ドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioph…